erlotinib hydrochloride has been researched along with withaferin a in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (withaferin a) | Trials (withaferin a) | Recent Studies (post-2010) (withaferin a) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 590 | 22 | 454 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | withaferin a (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.585 | |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.047 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.047 | |
| Transcription factor p65 | Homo sapiens (human) | 0.047 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaul, SC; Kumar, V; Malik, V; Sundar, D; Wadhwa, R | 1 |
1 other study(ies) available for erlotinib hydrochloride and withaferin a
| Article | Year |
|---|---|
Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Caffeic Acids; Computational Biology; Computer Simulation; Dimerization; ErbB Receptors; Erlotinib Hydrochloride; Exons; Gene Deletion; Gene Expression Regulation, Neoplastic; Humans; Indolizines; Ligands; Lung Neoplasms; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Phenylethyl Alcohol; Quinazolines; Withanolides | 2021 |